Satoshi Hagimoto
Satoshi Hagimoto publishes mostly in Pulmonary and Respiratory Medicine, Infectious Diseases and Genetics, on topics such as COVID-19 Clinical Research Studies, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis and SARS-CoV-2 and COVID-19 Research.
- World rank
- #1,350,120 of 7,710,434 ranked researchers
- Rank in Japan
- #20,596 of 383,136
- Works
- 30
- Citations
- 410
- Citations per work
- 13.7
What does Satoshi Hagimoto research?
Satoshi Hagimoto's work is mostly in Medicine (51%), Biochemistry, Genetics and Molecular Biology (16%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1551.1%
- Medicine1551.1%
- Everything else1032.7%
- Life Sciences516.2%
- 1Pulmonary and Respiratory Medicine21% of their works
- 2Infectious Diseases17% of their works
- 3Genetics8% of their works
- 4Molecular Biology8% of their works
- 5Oncology7% of their works
- 6Epidemiology6% of their works
Research topics
- COVID-19 Clinical Research Studies
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- SARS-CoV-2 and COVID-19 Research
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Single-cell and spatial transcriptomics
- Long-Term Effects of COVID-19
- Systemic Sclerosis and Related Diseases
- Cancer-related molecular mechanisms research
Which keywords describe Satoshi Hagimoto's research?
The keywords of their largest research topics: ACE2 Receptor, SARS-CoV-2, Fibrosis, Clinical Characteristics, Epidemiology, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease and COPD.
- Cancer
- Systemic Sclerosis
- Post-acute COVID-19 Syndrome
- Autoantibodies
- Vaccine
- COPD
- Idiopathic Pulmonary Fibrosis
- Clinical Characteristics
- SARS-CoV-2
- ACE2 Receptor
- Fibrosis
- Epidemiology
- Interstitial Lung Disease
- Coronavirus
- spirometry
- Neurologic Manifestations
- Single-Cell
- Transcriptomics
- Long Noncoding RNAs
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- ACE2 Receptor132 topics
- SARS-CoV-2132 topics
- Fibrosis92 topics
- Clinical Characteristics81 topic
- Epidemiology81 topic
- Idiopathic Pulmonary Fibrosis61 topic
- Interstitial Lung Disease61 topic
- COPD51 topic
- Coronavirus51 topic
- Vaccine51 topic
- spirometry51 topic
- Autoantibodies31 topic
- Neurologic Manifestations31 topic
- Post-acute COVID-19 Syndrome31 topic
- Single-Cell31 topic
- Systemic Sclerosis31 topic
- Transcriptomics31 topic
- Cancer21 topic
- Long Noncoding RNAs21 topic
Where does Satoshi Hagimoto work?
Satoshi Hagimoto's main affiliation in the publication record is Tosei General Hospital, Japan.
How many publications and citations does Satoshi Hagimoto have?
OpenAlex counts 30 works and 410 citations for Satoshi Hagimoto, an h-index of 10, ranking #1,350,120 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Satoshi Hagimoto. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.